Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 10/17/2025LEO Pharma's Anzupgo Cream NDA Accepted in China
  • 10/17/2025RemeGen's Telitacicept Demonstrates Strong Phase 3 Efficacy in Lupus, ...
  • 10/16/2025Belite Bio Secures Priority Review from China's NMPA for Tinlarebant
  • 10/16/2025Qilu Presents Promising Phase I Data for AR PROTAC Degrader QLH12016
  • 10/15/2025Sino Biopharma's TQB2102 Receives Breakthru Therapeutic Designation in...
  • 10/14/2025GSK's Shingrix Wins Chinese Approval for Expanded Use
  • 10/14/2025Biokin and SystImmune Present Promising Early Data for EGFR×HER3 Bisp...
  • 10/14/2025Multitude Reports Updated Safety and Dose Findings for AMT-116 at ESMO...
  • 10/14/2025AskBio Reports Promising Safety Results from First Cohort of AB-1003 G...
  • 10/13/2025Lepu Reports Early Clinical Data for ADC Programs in Various Cancers
  • 10/13/2025Hansoh Pharma Reports Phase II Data for Oral B7H3 ADC HS-20093
  • 10/13/2025Lundbeck's Epilepsy Drug Bexicaserin Granted Breakthrough Therapy Stat...
  • 10/13/2025Two Decades of Pediatric Drug Trials in China Reveal Progress and Pers...
  • 10/13/2025Kelun-Biotech Presents Promising Phase 1 Data for CLDN18.2 ADC SKB315
  • 10/13/20254B Technologies' Novel NGF Receptor Inhibitor 4B03-04 Receives FDA IND...
  • 10/13/2025Hope Medicine Reports Positive Global Phase 2 Results for HMI-115
  • 10/13/2025Kelun-Biotech Wins China Approval for TROP2 ADC in EGFR-Mutant NSCLC A...
  • 10/13/2025USB's Zilbrysq Wins Chinese Approval
  • 10/13/2025CSPC's Novel siRNA Therapy Gains U.S. Green Light for Clinical Trials
  • 10/3/2025Santen and RemeGen Files Chinese BLA for RC28-E
  • 10/3/2025Medilink Initiates U.S. Phase 1/2 Trial for VEGF-Targeted ADC YL242
  • 9/25/2025SystImmune to Unveil New Clinical Data on Two ADC Programs at ESMO 202...
  • 9/24/2025NMPA Accepts Alphamab's NDA for HER2 BsAb in Gastric Cancer
  • 9/24/2025Fosun Kairui Submits Marketing Application for Brexucabtagene Autoleuc...
  • 9/23/2025Leads Biolabs' LBL-047 Wins FDA Clearance, Advances Toward Clinical Tr...
  • 9/23/2025KeyMed Initiates First Phase 3 Trial for CD3/BCMA BsAb CM336
  • 9/23/2025IASO Bio Presents 36-Month Data for Fucaso
  • 9/22/2025Ascletis' ASC47 Combined with Semaglutide Shows Superior Weight Loss a...
  • 9/22/2025MagicRNA Publishes First-in-Human Data for In Vivo CAR-T Therapy in SL...
  • 9/22/2025Leads Biolabs Wins FDA Clearance for IND of LBL-047
  • Page:1/20 Total number of articles:583: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group